Kết quả phẫu thuật nội soi sửa van hai lá điều trị bệnh hở van hai lá đơn thuần

Mitral valve repair remains the treatment of choice for severe mitral regurgitation. In recent years, minimally invasive surgery is widespread and there is a growing tendency to gradually replace the traditional surgical procedure through median sternotomy. We sought to document the feasibility, safety, and effectiveness of performing mitral valve repair using an endoscopic approach. A total of 122 patients underwent endoscopic mitral valve repair during five years. Peripheral cardiopulmonary bypass was established via femoral artery, femoral veinous and right internal jugular vein. We used the retraction sutures as a left atrial retractor to improve mitral valve exposure. Patient characteristics, short-term outcomes, and complications were analyzed and reported. Mean age was 54.5 ± 14.2 years and their mean log EuroSCORE II was 1.53 ± 1.30. Mean aortic cross-clamp time was 117 ± 39 mins, cardiopulmonary bypass time was 181 ± 48 mins. The rate of repair was 96%. Thirtyday mortality was 2.5%. Endoscopic mitral valve repair can be safely performed under the surgical procedure in our institute with excellent short-term results and a high degree of patient satisfaction.